These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 23985881)

  • 41. Concentrations and specific antibodies to staphylococcal enterotoxin-C and toxic shock syndrome toxin-1 in bovine mammary gland secretions, and inflammatory response to the intramammary inoculation of these toxins.
    Kuroishi T; Komine K; Kai K; Itagaki M; Kobayashi J; Ohta M; Kamata S; Kumagai K
    J Vet Med Sci; 2003 Aug; 65(8):899-906. PubMed ID: 12951423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant expression and neutralizing activity of an MHC class II binding epitope of toxic shock syndrome toxin-1.
    Rubinchik E; Chow AW
    Vaccine; 2000 Apr; 18(21):2312-20. PubMed ID: 10717352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of antibody to toxic shock syndrome toxin-1 in burn patients.
    Park JY; Kim JS; Woo H
    Ann Lab Med; 2015 Jan; 35(1):89-93. PubMed ID: 25553286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [IgG antibodies to toxic shock syndrome toxin-1 (TSST-1) in human sera].
    Dickgiesser N; Kustermann B
    Klin Wochenschr; 1987 Mar; 65(6):256-8. PubMed ID: 3586568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
    Kum WW; Chow AW
    J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patterns of Staphylococcus aureus colonization, toxin production, immunity and illness in burned children.
    Childs C; Edwards-Jones V; Heathcote DM; Dawson M; Davenport PJ
    Burns; 1994 Dec; 20(6):514-21. PubMed ID: 7880416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low incidence of toxic shock syndrome in children with staphylococcal infection.
    Jacobson JA; Kasworm EM; Reiser RF; Bergdoll MS
    Am J Med Sci; 1987 Dec; 294(6):403-7. PubMed ID: 3425588
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibodies against superantigenic exotoxins produced by Staphylococcus aureus in sera from mothers and their infants' cord blood.
    Takahashi N; Hattori M; Miwa K; Nishida H
    Am J Perinatol; 2006 Oct; 23(7):413-9. PubMed ID: 17004199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia.
    Kanclerski K; Söderquist B; Kjellgren M; Holmberg H; Möllby R
    J Med Microbiol; 1996 Mar; 44(3):171-7. PubMed ID: 8636933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome.
    Gampfer J; Thon V; Gulle H; Wolf HM; Eibl MM
    Vaccine; 2002 Jan; 20(9-10):1354-64. PubMed ID: 11818153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Passive protection of rabbits infected with toxic shock syndrome-associated strains of Staphylococcus aureus by monoclonal antibody to toxic shock syndrome toxin 1.
    Scott DF; Best GK; Kling JM; Thompson MR; Adinolfi LE; Bonventre PF
    Rev Infect Dis; 1989; 11 Suppl 1():S214-7; discussion S217-8. PubMed ID: 2928638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of specific antibodies in cord blood, infant and maternal saliva and breast milk to staphylococcal toxins implicated in sudden infant death syndrome (SIDS).
    Harrison LM; Morris JA; Bishop LA; Lauder RM; Taylor CA; Telford DR
    FEMS Immunol Med Microbiol; 2004 Sep; 42(1):94-104. PubMed ID: 15325402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T-cell response to superantigen restimulation during menstrual toxic shock syndrome.
    Rasigade JP; Thomas D; Perpoint T; Peyramond D; Chidiac C; Etienne J; Vandenesch F; Lina G; Ferry T
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):368-71. PubMed ID: 21492259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Staphylococcal toxic shock syndrome: superantigen-mediated enhancement of endotoxin shock and adaptive immune suppression.
    Kulhankova K; King J; Salgado-Pabón W
    Immunol Res; 2014 Aug; 59(1-3):182-7. PubMed ID: 24816557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of a carboxy-terminal site of toxic shock syndrome toxin 1 in eliciting immune responses of human peripheral blood mononuclear cells.
    Drynda A; König B; Bonventre PF; König W
    Infect Immun; 1995 Mar; 63(3):1095-101. PubMed ID: 7532624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human peripheral gammadelta T cells potentiate the early proinflammatory cytokine response to staphylococcal toxic shock syndrome toxin-1.
    Kalyan S; Chow AW
    J Infect Dis; 2004 May; 189(10):1892-6. PubMed ID: 15122526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A new exanthematous disease in newborn infants caused by exotoxins producing Staphylococcus aureus; exotoxins production of the isolates and serum levels of antitoxin antibody in the patients and umbilical cord blood].
    Okada T; Furukawa S; Miwa K; Sakai R; Sugiyama J
    Kansenshogaku Zasshi; 1999 Sep; 73(9):893-900. PubMed ID: 10535264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin 1 following nongenital staphylococcal infection.
    Jacobson JA; Kasworm E; Daly JA
    Rev Infect Dis; 1989; 11 Suppl 1():S8-13. PubMed ID: 2928655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epithelial proinflammatory response and curcumin-mediated protection from staphylococcal toxic shock syndrome toxin-1.
    Schaefers MM; Breshears LM; Anderson MJ; Lin YC; Grill AE; Panyam J; Southern PJ; Schlievert PM; Peterson ML
    PLoS One; 2012; 7(3):e32813. PubMed ID: 22431984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of toxic shock syndrome toxin-1 by the accessory gene regulator in Staphylococcus aureus is mediated by the repressor of toxins.
    Tuffs SW; Herfst CA; Baroja ML; Podskalniy VA; DeJong EN; Coleman CEM; McCormick JK
    Mol Microbiol; 2019 Oct; 112(4):1163-1177. PubMed ID: 31321813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.